Company Details

Xi'an Henrikang Biotech Co.,Ltd [Shaanxi,China] Business Type: Manufacturer , Trade Company Main Markets: Africa , Americas , East Europe , Europe , Middle East , North Europe , West Europe , Worldwide Exporter: 81% - 90% Certs: ISO9001, API, CE Description: Edoxaban Vs Apixaban Powder,Edoxaban Reversal Agent,Edoxaban Antidote Powder

Inquiry Basket ( 0 )

Select Language

English

Home > Products > Human APIs > Antimicrobial agents > Antidote Apixaban And Edoxaban Reversal Agent Powder

Antidote Apixaban And Edoxaban Reversal Agent Powder

Unit Price:	350~500 USD
Payment Type:	L/C,T/T,D/P,D/A
Incoterm:	FOB,CFR,CIF,EXW,FCA,CPT,CIP,FA
Min. Order:	1 Kilogram

 Antidote Apixaban And Edoxaban Reversal Agent Powder

Basic Info

Model No.: HRK-edoxaban

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Grade: Pharmaceutical Grade

Molecular Weight: 720.26

Molecular Formula: C31h38cln7o7s2

CAS: 480449-70-5

Product Name: Hrk-Edoxaban

Active Ingredient: Edoxaban

Sample: Edoxaban Avaliable

Additional Info

Packaging: 1kg per bag. or customized packaging.

Productivity: 100000 kg

Transportation: Ocean,Land,Air,Express

Place of Origin: Shaanxi,China

Supply Ability: 600000 kg/months

Certificate: ISO

HS Code: N/A

Port: Shanghai,Qingdao,Guangzhou

Payment Type: L/C,T/T,D/P,D/A

Incoterm: FOB,CFR,CIF,EXW,FCA,CPT,CIP,FA

Product Description

Antidote apixaban and edoxaban reversal agent powder

Product Name:antidote apixaban and edoxaban reversal agent powder

What is edoxaban ?

Edoxaban (tosylate Monohydrate) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Edoxaban (tosylate Monohydrate) was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery.

Function of edoxaban :

Edoxaban (tosylate Monohydrate) is used for Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant.To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF).

Application of edoxaban :

1.Edoxaban (tosylate Monohydrate) is used for Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5 to 10 days of initial therapy with a parenteral anticoagulant.To reduce the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF).
2. Limitations of use
Edoxaban (tosylate Monohydrate) should not be used in nonvalvular atrial fibrillation (NVAF) patients with a creatinine clearance (CrCl) greater than 95 mL/minute because of an increased risk of ischemic stroke compared to warfarin.

Product Name

antidote apixaban and edoxaban reversal agent powder

specification

99%

certificate

ISO 9001

Keywords

Bulk edoxabanl , edoxaban powder , pure edoxaban

Test method

HPLC

Edoxaban

Xi'an Henrikang Biotech Co., Ltd., was established in May 2010, and located in Gaoling Industrial Park, Xi`an city, Shaanxi Province, China. It is a professional supplier of Healthcare Products, Vitamin And Enzyme, Human Apis, Cosmetic Raw, Veterinary Products, Food Additives, plant extract and natural active ingredients. It has absolute advantage because of strong research strength, modern management system and high-quality marketing team.

Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world.

For customer`s needs, OEM service is also acceptable. If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.